US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

32.16

-6.1145-15.98%

Pre-market: 32.770.6145+1.91%06:14 EDT

Volume:361.49K

Turnover:11.57M

Market Cap:63.98M

PE:- -

High:35.79

Open:35.40

Low:30.47

Close:38.27

52wk High:391.58

52wk Low:12.38

Shares:1.99M

Float Shares:1.99M

Volume Ratio:0.93

T/O Rate:18.17%

Dividend:1.98

Dividend Rate:6.16%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hims & Hers Sets Second-quarter Results Release and Investor Call

Hims & Hers's Peptide Opportunity Remains in Focus

Hims & Hers Health is Maintained at Neutral by B of a Securities

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)

Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56

Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Hims & Hers Health (HIMS) Secures $400 Million Financing, Is The Upside Already Priced In?

Simply Wall St.

Hims & Hers Health - Receivables Purchase Agreement Has Initial 364-day Term, Extendable by Written Agreement - SEC Filing

THOMSON REUTERS

Hims & Hers Signs USD 400 Million Receivables Purchase Facility with Jpmorgan Chase

Sector Update: Healthcare

MT Newswires Live

BofA Securities Adjusts Hims & Hers Health Price Target to $36 From $25, Maintains Neutral Rating

MT Newswires Live

Hims & Hers Health is Maintained at Neutral by B of a Securities

HIMS Stock Jumps after Canaccord Raises Price Target to Street-High of $40

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)

Hims & Hers : Bofa Global Research Raises Price Objective to $36.00 from $25.00

THOMSON REUTERS

Moderately bullish activity in Hims and Hers Health with shares up 5.3%

Analysis-hims' Obesity Drug Business May Get Boost as Employers Drop Coverage

Hims & Hers CFO Oluyemi Okupe sells 18,197 common shares worth $619,043 under 10b5-1 plan

Cboe data suggests bullish flow in Hims and Hers Health with shares up 11.49%

Living Longer Is Big Business. These Stocks Will Benefit. -- Barrons.com

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/HIMZ/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HIMZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","market":"US","secType":"STK","nameCN":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","latestPrice":32.1555,"timestamp":1787601600000,"preClose":38.27,"halted":0,"volume":361485,"hourTrading":{"tag":"盘前","latestPrice":32.77,"preClose":32.1555,"latestTime":"06:14 EDT","volume":1901,"amount":61884.7738,"timestamp":1787652846220,"change":0.6145,"changeRate":0.01911,"amplitude":0.009019},"delay":0,"changeRate":-0.1597726678860726,"floatShares":1989605,"shares":1989605,"eps":0,"marketStatus":"Pre-Mkt","change":-6.1145,"latestTime":"08-25 06:30:52 EDT","open":35.4,"high":35.785,"low":30.471,"amount":11565964.530045,"amplitude":0.138856,"askPrice":32.88,"askSize":60,"bidPrice":32.65,"bidSize":20,"shortable":0,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":32.1555,"sharesOutstanding":57385000,"nav":38.4,"aum":76400908.8,"dividendRate":0.061576,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":32.77,"preClose":32.1555,"latestTime":"06:14 EDT","volume":1901,"amount":61884.7738,"timestamp":1787652846220,"change":0.6145,"changeRate":0.01911,"amplitude":0.009019},"postHourTrading":{"tag":"盘后","latestPrice":32.1542,"preClose":32.1555,"latestTime":"19:54 EDT","volume":2515,"amount":80926.8599,"timestamp":1787615642256,"change":-0.0013,"changeRate":-0.00004,"amplitude":0.005492},"volumeRatio":0.9252415814111873,"impliedVol":1.4486,"impliedVolPercentile":0.288},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","floatShares":1989605,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9252415814111873,"shares":1989605,"dividePrice":1.98,"high":35.785,"amplitude":0.138856,"preClose":38.27,"low":30.471,"week52Low":12.3816,"pbRate":"--","week52High":391.58,"institutionHeld":0,"latestPrice":32.1555,"committee":-0.5,"eps":0,"divideRate":0.061576,"volume":361485,"delay":0,"ttmEps":0,"open":35.4,"prevYearClose":81.06,"prevWeekClose":38.27,"prevMonthClose":27.69,"prevQuarterClose":48.7861,"fiveDayClose":28.24,"twentyDayClose":34.21,"sixtyDayClose":28.57},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIMZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-19","symbol":"HIMZ","defaultRemindTime":1773927000000,"type":"split","dateTimestamp":1773892800000,"forFactor":14,"toFactor":1,"ratio":14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIMZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIMZ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIMZ\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651419401","title":"Hims & Hers Sets Second-quarter Results Release and Investor Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2651419401","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651419401?lang=en_us&edition=fundamental","pubTime":"2026-07-14 04:05","pubTimestamp":1783973156,"startTime":"0","endTime":"0","summary":"Hims & Hers sets second-quarter results release and investor callHims & Hers schedules second-quarter 2026 results for Aug. 10, 2026.Conference call set for Aug. 10, 2026 at 5 p.m. ET, following the m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL8fblfc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","HIMZ","HIYY","BK4196","HEAL","HIMS","HMYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650755249","title":"Hims & Hers's Peptide Opportunity Remains in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2650755249","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650755249?lang=en_us&edition=fundamental","pubTime":"2026-07-10 00:14","pubTimestamp":1783613640,"startTime":"0","endTime":"0","summary":"1214 ET - Hims & Hers Health is likely to beat estimates and raise its full-year guidance when it reports second-quarter results, but its potential opportunity in peptides is the biggest thing on investors' minds, Truist Securities analysts say in a note. The analysts point to credit-card data from June, which shows strong trends in the telehealth company's GLP-1 business as the rest of its business remains stable, they say. However, the stock has gained lately due to enthusiasm around the company's potential in peptides, making for a tough risk-reward setup for shares heading into the Food and Drug Administration's advisory committee meeting later this month, which will consider several peptides, the analysts say. Even if the committee gives a favorable recommendation, Hims likely wouldn't see any meaningful revenue boost from a potential peptide offering before 2028, the analysts say.  Dow Jones NewswiresJuly 09, 2026 12:14 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HMYY","THNR","HIMZ","BK4196","HIMS","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650296659","title":"Hims & Hers Health is Maintained at Neutral by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2650296659","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650296659?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:38","pubTimestamp":1783597080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings(END) Dow Jones NewswiresJuly 09, 2026 07:38 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIYY","HEAL","HIMY","HIMZ","HMYY","HIMS","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650923855","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650923855","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650923855?lang=en_us&edition=fundamental","pubTime":"2026-07-09 17:50","pubTimestamp":1783590627,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Tarsus Pharmaceutica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIYY","HIMZ","BK4007","THNR","TARS","HMYY","HEAL","HIMS","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649865930","title":"Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2649865930","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649865930?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:21","pubTimestamp":1783455682,"startTime":"0","endTime":"0","summary":"Hims & Hers CFO Oluyemi Okupe disposes of 7,163 common shares for $261,540.56Hims & Hers CFO Oluyemi Okupe sold 7,163 Class A shares at an average price of $36.49 on July 6, 2026.The sale followed the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL9VLQww:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMZ","HEAL","HIMY","THNR","HIMS","HMYY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649690202","title":"Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649690202","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649690202?lang=en_us&edition=fundamental","pubTime":"2026-07-05 14:00","pubTimestamp":1783231200,"startTime":"0","endTime":"0","summary":"Many Americans would love a drug that makes them fitter, sharper, and more attractive. The peptides industry aims to oblige, and sales may soon be off to the races, courtesy of the Trump Administratio","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","IE00BKVL7J92.USD","HIMY","BK4532","HIMZ","HMYY","IE00BZ1G4Q59.USD","LU1093756168.USD","LU1093756325.SGD","BK4196","HIYY","OZEM","HIMS","LU0154236417.USD","BK4599","NVO","NVOH","BK4588","PPH","BK4585","BK4007","THNR","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648503293","title":"Hims & Hers Health (HIMS) Secures $400 Million Financing, Is The Upside Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648503293","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648503293?lang=en_us&edition=fundamental","pubTime":"2026-07-02 14:41","pubTimestamp":1782974499,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) is back in focus after securing a $400 million financing arrangement with JPMorgan Chase Bank. This move improves liquidity while regulatory scrutiny of its peptide ambitions intensifies.\nSee our latest analysis for Hims & Hers Health.\nAt a share price of $37.57, Hims & Hers Health has seen strong short term momentum, with a 1 month share price return of 35.34% and 90 day share price return of 96.29%, while the 1 year total shareholder return declined 20.84% but the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-secures-400-million-financing-is-the-u","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-secures-400-million-financing-is-the-u","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HIYY","HIMZ","HMYY","HIMS","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648256529","title":"Hims & Hers Health - Receivables Purchase Agreement Has Initial 364-day Term, Extendable by Written Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2648256529","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648256529?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:03","pubTimestamp":1782939813,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nFWN433146:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIYY","HIMS","HIMY","HIMZ","HMYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648529254","title":"Hims & Hers Signs USD 400 Million Receivables Purchase Facility with Jpmorgan Chase","url":"https://stock-news.laohu8.com/highlight/detail?id=2648529254","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648529254?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:03","pubTimestamp":1782939803,"startTime":"0","endTime":"0","summary":"Hims & Hers signs USD 400 million receivables purchase facility with JPMorgan ChaseHims & Hers subsidiaries XeCare, Apostrophe Pharmacy entered a Master Receivables Purchase Agreement with JPMorgan on","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL96VZhv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002224.SGD","LU2430703178.SGD","LU2756315318.SGD","IE00BYXW3230.USD","LU2237443978.SGD","LU0320765489.SGD","LU0345770308.USD","LU0820562030.AUD","LU2417539215.USD","LU0238689110.USD","LU2505996509.AUD","LU2552382132.HKD","IE0034235295.USD","LU2106854487.HKD","LU1032466523.USD","LU1145028129.USD","LU0106831901.USD","LU0251132253.USD","LU1244550494.USD","LU1914381329.SGD","JPX","LU0868494617.USD","LU1084165304.USD","LU2242649171.HKD","BK4207","IE00B775SV38.USD","LU0234572021.USD","BK4504","LU2430703251.USD","LU0215105999.USD","LU2592432038.USD","IE0034235188.USD","LU0265550359.USD","IE00BBT3K403.USD","BK4516","LU1548497426.USD","LU0006306889.USD","LU1988902786.USD","BK4534","LU0964807845.USD","LU0310799852.SGD","LU2746668461.USD","IE00B1BXHZ80.USD","LU0820561818.USD","LU0170899867.USD","HIMS","LU0787776722.HKD","IE00BJLML261.HKD","LU1064131342.USD","LU0256863811.USD","LU2756315664.SGD","BK4585","LU1668664300.SGD","IE00BLSP4452.SGD","LU1496350171.SGD","BK4550","LU1363072403.SGD","LU0187121727.USD","LU0070302665.USD","LU0048584097.USD","LU0496365809.HKD","HIYY","BK4581","LU2746668974.SGD","LU0640476718.USD","LU0211326839.USD","BK4566","LU0417517546.SGD","LU0971096721.USD","LU1267930490.SGD","LU1670627923.USD","HIMZ","LU0689472784.USD","LU0208291251.USD","IE00BDRTCR15.USD","BK4533","LU1974910355.USD","IE00BWXC8680.SGD","LU2023250504.SGD","IE00BFXG1179.USD","LU2462157665.USD","LU1670628061.USD","BK4196","LU1629891620.HKD","LU2357627491.SGD","LU1917777945.USD","HMYY","LU2237443465.HKD","LU2237443895.HKD","LU0203347892.USD","LU0942090050.USD","LU2211815571.USD","LU2381873111.SGD","LU2236285917.USD","LU1244550577.SGD","LU2023250843.SGD","IE00BKVL7J92.USD","LU2552382058.USD","IE00BHPRN162.USD","LU2456880835.USD","LU1551013425.SGD","LU0820561909.HKD","LU1261432733.SGD","LU2237443382.USD","IE00BDCRKT87.USD","LU1720051017.SGD","LU1894683348.USD","LU1244550221.USD","LU2264538146.SGD","LU0267386448.USD","BK4588","LU0345770993.USD","LU2237443622.USD","LU1162221912.USD","LU1496350502.SGD","IE00B1XK9C88.USD","IE00B3S45H60.SGD","LU0203345920.USD","LU1366192091.USD","LU0234570918.USD","IE00BJTD4N35.SGD","LU0868494708.USD","LU0943347566.SGD","JPM","LU2505996681.GBP","IE0034235303.USD","IE00BJTD4V19.USD","LU0323591593.USD","JPMO","LU2430703095.HKD","HIMY","LU2213496289.HKD","LU1894683264.USD","LU1116320901.HKD","LU0683600562.USD","IE00BKDWB100.SGD","IE00BN8TJ469.HKD","LU1280957306.USD","LU2552382215.SGD","JPO","LU2244417387.USD","LU0859254822.USD","LU0149725797.USD","LU0345769631.USD","LU0976567544.SGD","LU2023250330.USD","LU0345769128.USD","IE00BLSP4239.USD","LU1551013342.USD","LU2237443549.SGD","LU1119994496.HKD","IE000M9KFDE8.USD","LU0211331839.USD","LU0320765646.SGD","LU2054465674.USD","LU0211327993.USD","IE00BZ1G4Q59.USD","LU0265550946.USD","LU2357305700.SGD","LU0211328371.USD","LU1720051108.HKD","LU0106261372.USD","SG9999002232.USD","LU0882574139.USD","LU0211326755.USD","LU0256863902.USD","LU1116320737.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648540507","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2648540507","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648540507?lang=en_us&edition=fundamental","pubTime":"2026-07-02 01:19","pubTimestamp":1782926397,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index increasing 0.1% and the State Street Health Care Select Sector SPDR ETF  adding 0.4%.The iShares Biotechnology ETF  was fractionally higher.In corporate news, Hims & Hers Health  shares jumped past 8% after BofA Securities lifted the company's price target to $36 from $25, while keeping its neutral rating.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XBI","BK4581","BK4137","HIYY","HIMY","HCSG","BK4585","BK4588","LU0128526141.USD","BK4196","HMYY","HIMZ","LU0029874061.USD","LABU","XLV","IBB","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648940549","title":"BofA Securities Adjusts Hims & Hers Health Price Target to $36 From $25, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2648940549","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648940549?lang=en_us&edition=fundamental","pubTime":"2026-07-01 22:06","pubTimestamp":1782914817,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) has an average rating of Hold and mean price target of $29.27, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HIMS","HIMY","HIMZ","HMYY","HIYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648543734","title":"Hims & Hers Health is Maintained at Neutral by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2648543734","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648543734?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:52","pubTimestamp":1782910320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings(END) Dow Jones NewswiresJuly 01, 2026 08:52 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HIMZ","BK4196","HMYY","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648154824","title":"HIMS Stock Jumps after Canaccord Raises Price Target to Street-High of $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2648154824","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648154824?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:16","pubTimestamp":1782908218,"startTime":"0","endTime":"0","summary":"Shares of Hims & Hers ($HIMS) rose in pre-market trading after receiving a new Street-high price target of $40. Canaccord Genuity analyst Maria Rip...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/hims-stock-jumps-after-canaccord-raises-price-target-to-street-high-of-40?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/hims-stock-jumps-after-canaccord-raises-price-target-to-street-high-of-40?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIYY","HIMS","HMYY","HIMY","BK4196","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648510005","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648510005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648510005?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:01","pubTimestamp":1782907265,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims &...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-oruka-therapeutics-orka-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-oruka-therapeutics-orka-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["04332","IE0009355771.USD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU2242646821.SGD","LU0058720904.USD","AMGN","LU0889565916.HKD","HMYY","LU2242652126.USD","BK4588","LU1023059063.AUD","LU2112291526.USD","LU0868494617.USD","LU0289739699.SGD","BK4599","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1057294990.SGD","HIMS","IE00BJT1NW94.SGD","HIYY","HIMY","LU0320765992.SGD","HIMZ","ORKA","IE00B2B36J28.USD","LU1983299246.USD","LU2089984988.USD","BK4533","BK4196","SG9999001440.SGD","BK4566","BK4139","IE0002141913.USD","BK4581","BK4534","BK4585","LU1571399168.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648517550","title":"Hims & Hers : Bofa Global Research Raises Price Objective to $36.00 from $25.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2648517550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648517550?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:05","pubTimestamp":1782903937,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nAZN4T5E2P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIYY","HIMY","BK4196","HMYY","HIMZ","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646369411","title":"Moderately bullish activity in Hims and Hers Health with shares up 5.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646369411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646369411?lang=en_us&edition=fundamental","pubTime":"2026-06-26 23:55","pubTimestamp":1782489309,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Hims and Hers Health (HIMS), with shares up $1.74, or 5.3%, near $34.45. Options volume running well above average w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-5-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-5-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMZ","HIMY","BK4196","HMYY","HIMS","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646879143","title":"Analysis-hims' Obesity Drug Business May Get Boost as Employers Drop Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2646879143","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646879143?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:00","pubTimestamp":1782381600,"startTime":"0","endTime":"0","summary":"CORRECTED-ANALYSIS-Hims' obesity drug business may get boost as employers drop coverageCorrects paragraph 15 to reflect that Hims & Hers is one of the most volume-producing of Novo’s partners, and not","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL1N42O14W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMS","BK4588","HIMZ","IE00B19Z3B42.SGD","BK4196","LU0868494617.USD","CI","TFC","LU0058720904.USD","HMYY","LU1059921491.USD","IE0002270589.USD","ESCA","BK4211","IE00BSNM7G36.USD","LU1261432733.SGD","LU0289739699.SGD","LU2237438978.USD","HIYY","IE00B19Z3581.USD","BK4585","BK4190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645852702","title":"Hims & Hers CFO Oluyemi Okupe sells 18,197 common shares worth $619,043 under 10b5-1 plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2645852702","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645852702?lang=en_us&edition=fundamental","pubTime":"2026-06-24 06:40","pubTimestamp":1782254411,"startTime":"0","endTime":"0","summary":"Hims & Hers Health CFO Oluyemi Okupe sold 18,197 Class A shares on June 22 at an average $34.03.He exercised options for 6,376 shares at $5.01 the same day.Directly held stake ended at 284,321 shares; an additional 7,853 shares were held indirectly via a trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL64Qc8G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CFO Oluyemi Okupe sells 18,197 common shares worth $619,043 under 10b5-1 plan","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HIMS","HMYY","HIMY","BK4196","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644103924","title":"Cboe data suggests bullish flow in Hims and Hers Health with shares up 11.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644103924","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644103924?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:45","pubTimestamp":1781815510,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Hims and Hers Health (HIMS), with shares up $3.67, or 11.49%, near $35.55. Options volume more than double the d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-hims-and-hers-health-with-shares-up-11-49-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-hims-and-hers-health-with-shares-up-11-49-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","HIMY","HIMS","HIYY","HIMZ","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644380030","title":"Living Longer Is Big Business. These Stocks Will Benefit. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2644380030","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644380030?lang=en_us&edition=fundamental","pubTime":"2026-06-19 02:15","pubTimestamp":1781806500,"startTime":"0","endTime":"0","summary":"Health is wealth goes the saying. Now it's an investment opportunity, too.The consumerization of healthcare is nothing new, but the pandemic turbocharged its widespread adoption. From telehealth appointments to digital patient portals and wearable trackers, many people began to treat their health like any other retail experience -- whether it's walking into a CVS Health MinuteClinic after doing some shopping, or trying  to estimate the out-of-pocket price for procedures with cost-estimator tools.The upshot is that longevity, i.e. not only living longer but being healthy for longer, could be big business for healthcare companies. TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion, with beneficiaries spanning companies making biological breakthroughs to those using artificial intelligence.\"Tools to measure and screen health status--across blood-based testing, imaging, and wearable--have advanced meaningfully,\" writes lead analyst Da","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","LU2264538146.SGD","LU1023059063.AUD","BK4121","LU0114720955.EUR","LU0354030438.USD","LU0868494617.USD","GB00BDT5M118.USD","QTRX","LU0289739699.SGD","BK4533","BTMD","LU2324357040.USD","BK4550","DXCM","IE00BFTCPJ56.SGD","CAVA","IE00B4R5TH58.HKD","PLNT","IE0009355771.USD","SG9999004303.SGD","BK4534","LU1983299246.USD","LU2095319765.USD","SGXZ23171101.USD","IE00BJT1NW94.SGD","LU0432979614.USD","LU2112291526.USD","LU1988902786.USD","LU2237957811.SGD","LU2065169927.USD","BK4196","LU2065731478.USD","BK4209","HIMS","LU0072461881.USD","IE0002141913.USD","LU0963586101.USD","BK4566","BK4548","BK4568","LU0390134368.USD","LU1914381329.SGD","SG9999002232.USD","LU1061106388.HKD","LU1699723380.USD","TDOC","IE00B2B36J28.USD","LU0320765489.SGD","LU2065170008.USD","BK4082","LU0058720904.USD","HIMY","IE00B19Z3581.USD","LU1323610961.USD","BFLY","LU2211815571.USD","OWLT","HIMZ","LU0006061336.USD","LU1861558580.USD","BK4216","BK4504","LU0070302665.USD","ABT","LU2065171402.SGD","LU2468319806.SGD","LU1989763690.USD","LU2210149790.SGD","BK4535","LU2210150020.SGD","HIYY","IE00B7SZLL34.SGD","CVS","LU1861559042.SGD","LU2125909247.SGD","LU0061475181.USD","IE00BMPRXN33.USD","LU1721429741.USD","LU2125909593.SGD","LU1057294990.SGD","LU1721429402.USD","LU2133065610.SGD","NTRA","IE00BKVL7J92.USD","LU0053671581.USD","LU0882574055.USD","LU0354030511.USD","LU0211331839.USD","LU0208291251.USD","IE0002270589.USD","LU0122379950.USD","IE00BJJMRZ35.SGD","BK4007","IE00BZ1G4Q59.USD","GH","LU0234572021.USD","LU0012050646.USD","LU1059921491.USD","IE00B19Z3B42.SGD","MYGN","LU0162691827.USD","BK4167","SGXZ41872573.SGD","BK4588","LU1923622614.USD","LU2065171311.SGD","SG9999002224.SGD","LU0266013472.USD","BK4139","BK4592","LU0345770308.USD","BK4551","BK4581","IE00BSNM7G36.USD","LU2237957902.USD","BK4585","LU1691799644.USD","IE00BMPRXR70.SGD","HMYY","BK4567","LU0345770993.USD","LU0170899867.USD","LU2433249047.HKD","LU1064131342.USD","LU0106261612.USD","LU1989763427.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}